Clinicians and researchers are invited to attend a webinar on 18 April 2024 led by A/Prof Greg Arndt, Head of the Australian Cancer Research Foundation (ACRF) Drug Discovery Centre at Children’s Cancer Institute, to learn of ways in which projects are reviewed and selected for the THINK Advanced Therapeutics Enabling Platform funded by Luminesce Alliance.

THINK is a disease-agnostic integrated pipeline of technologies, capabilities, and expertise that spans all stages of the drug discovery and development pathway for not only cancer, but also new projects in rare genetic diseases and neurodevelopmental disorders.

To find out more, including how to register, click here.